An experimental cancer drug developed by Kosan Biosciences Inc. could halt the disease in patients with a variety of cancers and may tackle cancers resistant to other drugs.
 
[CML]
A group of CMLHope.Com
Subscribe: [EMAIL PROTECTED]
Web Site: http://groups.cmlhope.com 

Reply via email to